Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02223533Phase 4Completed
Phase 4, randomised, open-label trial (2 arms), sponsored by Hospital Galdakao-Usansolo. Primary endpoints: Numerical Rating Scale Pain Score at 48 hours and Intravenous Morphine Consumption at 48 hours. Started Jan 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02223533.